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Indigo formation and rapid NADPH consumption provide robust prediction 
of raspberry ketone synthesis by engineered cytochrome P450 BM3. 
Olivier Rousseau [a,b,d], Maximilian C.C.J.C. Ebert [b,c,d], Daniela Quaglia [a,b,d], Ali Fendri [a,b,d], Adem H.-
Parisien [b,c,d], Jonathan N. Besna [b,c,d],Saathanan Iyathurai [b,c,d] and Joelle N. Pelletier [a,b,c,d] * 
Natural raspberry ketone has a high value in the flavor, fragrance and 
pharmaceutical industries. Its extraction is costly, justifying the search 
for biosynthetic routes. We hypothesized that cytochrome P450 BM3 
(P450 BM3) could be engineered to catalyze the hydroxylation of 4-
phenyl-2-butanone, a naturally sourceable precursor, to raspberry 
ketone. The synthesis of indigo by variants of P450 BM3 has 
previously served as a predictor of promiscuous oxidation reactions. 
To this end, we screened 53 active-site variants of P450 BM3 using 
orthogonal high-throughput workflows to identify the most streamlined 
route to all indigo-forming variants. Among the three known and 13 
new indigo-forming variants, eight hydroxylated 4-phenyl-2-butanone 
to raspberry ketone. Previously unreported variant A82Q displayed 
the highest initial rates and coupling efficiencies in synthesis of indigo 
and of raspberry ketone. It produced the highest total concentration of 
raspberry ketone despite producing less total indigo than previously 
reported variants. Its productivity, although modest, clearly 
demonstrates the potential for development of a biocatalytic route to 
raspberry ketone. In addition to validating indigo as a robust predictor 
of this promiscuous activity, we demonstrate that monitoring rapid 
NADPH consumption serves as an alternative predictor of a 
promiscuous reactivity in P450 BM3.
Introduction 
Substituted phenols are highly sought-after industrial 
intermediates and products.[1] Among these, 4-(4-hydroxyphenyl)-
2-butanone, also known as rheosmin or raspberry ketone, is of 
high value for the flavor and fragrance industry and is under 
investigation for its potential health benefits.[2] The cost of 
extracting natural raspberry ketone from raspberries and other 
fruits (20 000$/kg) justifies the development of synthetic and 
biosynthetic routes to access this small molecule.[3] In particular, 
biocatalytic routes can be applied to transform natural precursors 
into products then considered to be ‘natural’, offering regulatory 
advantages for applications in the food and fragrance markets.[3e] 
Cytochrome P450 oxidases constitute a superfamily of 
NAD(P)H-dependent mono-oxygenases that catalyze reactions 
on a wide range of substrates,[4] including the degradation of 
xenobiotics and endogenous molecules.[5] They catalyze 
hydroxylation, epoxidation, deamination, dehalogenation, 
dealkylation and more, acting on non-activated carbon atoms in a 
single step. The breadth of their reactivity gives them great 
industrial importance.[6] Cytochrome P450 oxidase BM3 (P450 
BM3), from Bacillus megaterium, is a self-sufficient cytochrome 
P450. Its reductase domain is fused to its heme domain, making 
it among the most efficient cytochrome P450 oxidases with 
respect to electron transfer. Although the primary physiological 
function of P450 BM3 remains unclear, fatty acids are its native 
substrates. The native P450 BM3 and, to a greater extent, its 
engineered variants, oxidize substrates as chemically diverse as 
methane, numerous terpenes and alkaloids, heteroaromatics and 
many natural and non-natural, bulkier molecules such as 
buspirone and dextromethorphan,[6a, 7] making P450 BM3 a 
versatile enzyme that offers good promiscuity for substrate 
discovery.  
Screening assays to explore the versatility of cytochrome 
P450s have been developed, particularly assays that rely on 
chromogenic or derivatized substrates and products.[8] Monitoring 
cytochrome P450 oxidase variants for the oxidation of indole to 
indoxyl is particularly attractive because indoxyl undergoes 
spontaneous oxidative dimerization to the readily-detectable deep 
blue pigment indigo (Figure 1A). Chromogenic reactions address 
one of the main bottlenecks of high-throughput screening: 
reactivity can be detected in whole cells or in cell lysate, reducing 
time and cost of screening as only well-expressed, active and 
soluble variants are identified in a high-throughput format.  
We hypothesized that P450 BM3 could be a potential 
candidate enzyme for the oxidative biotransformation of 4-phenyl-
2-butanone (4-PB) to raspberry ketone (Figure 1B). The substrate, 
4-PB, is a major fraction of the essential oils of the tropical 
Aquilaria trees and thus can be naturally sourced.[9] Neither 
substrate nor product of the reaction are obvious candidates for 
visual library screening. It has been demonstrated that screening 
cytochrome P450 variants for improved oxidative activity toward 
indigo formation can be a successful route to identifying variants 
that are promiscuously active. Substrates identified by that 
method include branched fatty acids, pentane, dioxins, cyclic 
terpenoids, coumarins and substituted aromatics, and 
polyaromatics such as toluene, indoles and quinolones.[10] Even 
modest levels of indigo synthesis have proven to be of value as a 
start-point for evolution toward broader substrate promiscuity and 
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Figure 1. Role of cytochrome P450 BM3 in (A) the biotransformation of indole 
to indigo and (B) the proposed biotransformation of 4-phenyl-2-butanone (4-PB) 
to raspberry ketone. 
One study of P450CAM variants found a 96% correlation 
between the hydroxylation of indole and an unrelated substrate, 
diphenylmethane.[10b] Here, we set out to verify the efficacy of 
indole oxidation in the microbial, self-sufficient P450 BM3 as a 
predictor of promiscuous activity for the unrelated substrate, 4-PB. 
Specifically, we considered it important to determine whether, 
independently of indigo production, all well-folded and functional 
BM3 variants are equally good candidates for this promiscuous 
activity. We verified whether variants exhibiting the highest indole 
oxidation to indigo correlated with the highest 4-PB oxidation. We 
also verified whether high NADPH consumption may be indicative 
of a greater propensity to oxidize 4-PB. We compare experimental 
outputs to determine the most efficient workflow to identify novel 
P450 BM3 variants that hydroxylate 4-PB to raspberry ketone. 
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Results and Discussion 
Indigo is among the oldest dyes and finds utility in diverse 
industries such as textiles, food, and pharmaceuticals.[12] 
Synthetic biology and biocatalytic solutions to indigo production 
have been sought in the past.[10b, 13] Among these, engineered 
variants of P450 BM3 have been found to be active toward the 
oxidation of indole to indoxyl, and thence to indigo.[7a, 7c] We 
sought to exploit the correlation that has been observed between 
that oxidative transformation and the oxidation of other non-native 
substrates in some cytochrome P450s to identify variants active 
in the production of raspberry ketone.  
The chemical space of P450 BM3 has been only lightly 
tapped into with respect to indigo-producing variants. With the aim 
of identifying new indigo-forming variants and broadening the 
search space for potential raspberry ketone production, we 
mutated and screened five active-site residues: V78, A82, F87, 
A264 and T268 (Figure 2). These positions were rationally 
selected based on distance from the heme-iron and side-chain 
orientation, and in some cases prior observation of indigo 
formation, as described below. 
 
Figure 2. The five active-site positions selected for mutagenesis in P450 BM3: 
V78, A82, F87, A264 and T268 in a close-up of the active-site (PDB code 1BU7). 
P450 BM3 is represented in green cartoon form and the heme in red sticks. 
Distances from the heme iron are shown (Å). 
Several variants at positions A82 and F87 have been well 
characterized in the oxidation of natural substrates, drugs and 
metabolites.[7c, 14] Some are also known to catalyze indigo 
formation and to significantly modify the active site geometry; 
those two positions were further diversified.[7a, 11a, 15] Some 
variants at position V78 oxidize small substrates, a feature that is 
compatible with our goal, justifying its inclusion.[16] Specific 
substitutions at position A264 displace the heme iron-coordinating 
water molecule, and others at the highly conserved T268 alter its 
role in the oxidation mechanism, demonstrating the impact of 
these core active-site positions on reactivity.[17] They were 
considered to be promising targets for modification. Site-
saturation mutagenesis was performed at these five positions 
using a mix of degenerate primers (Table S1).[18] We obtained a  
coverage of 50-70% at each position, yielding a dataset of 53 
variants (Table 1). 
 
Table 1. P450 BM3 variants screened in this study. 
Native residue Variants screened Coverage ( /19) 
V78 A, D, F, G, K, N, S, W, Y 9 
A82 C, E, F, G, I, K, L, P, Q, R, T, V, W 13 
F87 A, H, I, K, L, N, P, Q, S, V, W 11 
A264 C, D, F, G, N, P, R, T, V   9 
T268 A, D, E, G, K, M, N, P, S, W, Y   11 
Direct visual identification of indigo-forming bacterial 
colonies can be done upon plating on indole-containing 
medium[11a]. Though rapid, that method provides no quantification. 
In our search for indigo-producing variants, we directly assayed 
clarified cell lysate for indigo formation using a microtiter-well 
format to monitor absorbance at 620 nm after 2 h of reaction. This 
allows ample time for the primary oxidation product, indoxyl, to 
spontaneously dimerize into indigo.[19] Despite the poor water 
solubility of indigo, this method is sufficient to rank promising 
candidates. Direct absorbance in clarified lysate identified 14/53 
variants producing indigo (Figure S1). These include three known 
indigo-forming variants, A82F, A82W and F87V,[7a, 11a, 15] and we 
identified 11 unreported variants. Among these, substitutions at 
A82 and F87 displayed the highest activity; substitutions V78 and 
A264 also yielded positive hits. Only position T268 yielded no 
indigo-forming variants according to absorbance at 620 nm. We 
note that, although it produced detectable indigo, the 
concentration produced by the WT was below the limit of 
quantification in our method. 
We considered that 14 indigo-forming variants out of 53 
variants screened was quite successful. It has been 
demonstrated that indigo formation in P450 BM3 is useful in 
searching for novel transformations.[10] However, it is not known if 
indigo formation is a robust predictor. Specifically, how efficient is 
indigo formation in predicting variants displaying a novel reactivity 
and, in counterpart, are all variants displaying a novel reactivity 
indigo producers? To this end, we established a high-throughput 
workflow to accelerate the discovery of highly active variants that 
are independent of the indigo predictor, with a focus on NADPH 
consumption. We quantified functional expression of the 53 
variants and screened them for NADPH consumption, followed by 
product formation by mass spectrometry. 
We identified the variants that are well folded, including the 
heme iron, according to carbon monoxide (CO) difference 
spectroscopy in a microtiter plate format. [8a] This rapid and 
reliable quantification of functional expression of each variant 
demonstrated that 31 out of the 53 variants were functionally 
expressed (Figure S2). As expected, this included all 14 indigo-
positive variants. Under our conditions, we observed moderate 
variation of expression, as illustrated by the standard deviation on 
eight replicates of the wild-type P450 BM3. We note that SDS-
PAGE analysis of protein expression in lysates identified all CO-
test positive variants as being highly expressed; two further 
variants were highly expressed but negative in CO-testing (A82R 
and T268K), presumably because they did not successfully 
incorporate heme and/or iron (data not shown). Finally, this assay 
revealed one false positive, F87W, which was a weak producer in 
the Abs620 assay but was negative in the CO test and was not 
considered thereafter.  
We then optimized a NADPH-consumption fluorescence 
assay by adapting it to automation. This previously reported 96-
well plate assay can apply to any NADPH-consuming reaction, 
including non-colorigenic reactions. [20] Hits were defined as 
variants consuming NADPH faster in the presence than in the 
absence of exogenous substrate. The high-throughput workflow 
was validated toward the conversion of indole. We originally 
performed the reaction with 0.375 mM NADPH to observe initial 
rates. Under those conditions, the difference between presence/ 
absence of exogenous substrate did not allow the clear 
identification of indole-reactive variants (data not shown). We 
therefore designed an assay with 1.5 mM NADPH: initial rates are 
not directly observed due to saturation of the fluorescence 
detector but clear rate discrimination is observed upon complete 
consumption of NADPH (Figure S3). Under these conditions, the 
NADPH fluorescence assay unveiled 29/31 CO-positive variants 
where NADPH was consumed faster in the presence than in the 
absence of indole (Table S2). 
This result is substantially greater than the 14/53 indigo 
producers identified by Abs620. We observed that indole activated 
NADPH consumption: all the well-expressed variants consumed 
faster in presence of this exogenous substrate. The poorly-
expressed T268M and T268W variants do not exhibit this 
behaviour. NADPH consumption in the bacterial lysates can result 
from the activity of other NADPH-dependent enzymes, from 
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activity of P450 BM3 with endogenous substrates such as fatty 
acids or as a result of uncoupling of P450 BM3 to form H2O2, 
superoxide anion and water. [7a, 21]. Moreover, uncoupling can be 
substrate dependent: the T268A variant of P450 BM3 is known to 
exhibit uncoupling in the presence of C16 but not C14 fatty acid 
substrate. [22] The assay may therefore not be a direct reflection 
of product formation. We thus validated product formation by 
mass spectrometry for the indole-activated NADPH-consuming 
variants. 
 
Figure 3. Quantification of indigo by LC-MS (blue) and raspberry ketone by GC-
MS (red) for the 16 best indigo producing variants of P450 BM3. Assays were 
performed in the presence of 5 mM substrate and 1.5 mM NADPH. The limit of 
quantification (lowest concentration in the linear portion of the calibration curve) 
for both products was 1.25 μM, indicated with a dashed line. Product 
concentration in WT is the average eight replicates with standard deviation. 
Using LC-MS, we confirmed that 16 out of the 29 NADPH 
fluorescence hits showed detectable levels of indigo (Figure 3; 
Table S2; Figure S4). The higher sensitivity of LC-MS led to the 
detection of two additional variants than the Abs620 assay: A264V 
and A82G, which were among the weakest indigo producers 
(Figure S5; Table S3). We defined variants as being indigo 
producers if they produced indigo > 2 × the lowest concentration 
in the linear portion of the calibration curve (1.25 μM) (Figure 4). 
We thus identified 12 indigo producers by LC-MS (Figure 4; Table 
S3). This demonstrates that the straightforward Abs620 assay 
identified all the best indigo producers, serving as a rapid and 
robust screen that is compatible with large libraries. Prolonging 
the Abs620 assay beyond 2 h did not reveal further indigo 
producers, but shortening the assay reduced its sensitivity. LC-
MS being more sensitive, it also identified weakly active variants. 
In certain contexts, these variants can also be good starting points 
to evolve the enzyme toward new functions. 
Remarkably, more than half of the NADPH-consuming 
variants (16/29) gave indigo at concentrations ≥ 1.25 μM, 
demonstrating that active-site modification of P450 BM3 to 
oxidize indole is readily achievable. The previously reported 
variants A82F, A82W and F87V were among the most efficient 
indigo-producing variants.[7c, 23] Several of the best indigo 
producers are novel variants at those two positions (A82 and F87), 
such as F87P. It has been shown that aggressive substitution in 
P450 BM3, including substitution to proline, can be 
accommodated and result in unexpected and desirable outcomes. 
[21d] In addition, we report the first indigo-producing variants of 
position V78 and A264. Variant V78A (5th-best) was one of 
several mutations in variants reported to hydroxylate small 
alkanes [16b] or alter hydroxylation regiospecificity on C12 fatty 
acids.[24] Variants of position A264 were weaker: A264G and 
A264V yielded quantifiable indigo, though only A264G is 
considered an indigo producer (≥ 2.5 μM). Previously reported 
A264 substitutions to E, H, K, M, Q, or C all altered the heme iron 
ligand sets, inactivating the enzyme.[17a-c, 25] However, within 
multiply-substituted variants, A264G contributes to the oxidation 
of polycyclic aromatic hydrocarbons [26] whereas A264V 
contributes to the oxidation of a terpene. [27] The two variants of 
A264 identified here harbour those same conservative 
substitutions (A264G/V) and constitute, to our knowledge, the first 
report of point-substituted reactive variants of A264.  
Quantification of indigo allowed us to address the long-
standing debate of whether the wild-type P450 BM3 (WT) does [7a, 
28] or does not [11a, 15a] hydroxylate indole. Absorption at 620 nm in 
bacterial lysates (n=8) was not consistently observed within the 
linear range of quantification, confirming that WT is, at best, a 
poor indole oxidizer. Nonetheless, LC-MS unequivocally 
confirmed production of indigo (Figure S5). The average indigo 
concentration determined by LC-MS was 1.0 μM (Table S2). 
Indigo formation by WT P450 BM3 is thus detectable but indigo 
was not consistently produced above the lower limit of the 
calibration curve (1.25 μM).  
Our identification of 3 known and 13 unreported variants of 
P450 BM3 that synthesize indigo demonstrates that there are 
numerous engineering solutions to produce indigo with this 
enzyme. Based on this, P450 BM3 may not need tremendous 
engineering efforts to evolve for oxidation reactions on further 
non-native substrates. We verified whether the previously 
reported correlation between oxidation of indole and of other 
substrates [10a-c] also applies to the oxidation of 4-phenyl-2-
butanone (4-PB) to raspberry ketone. P450 BM3 has not been 
reported to synthesize raspberry ketone nor have any of its 
variants. GC-MS confirmed the presence of hydroxylated 4-PB at 
an average concentration of 1.15 μM, establishing hydroxylated 
4-PB formation by WT P450 BM3 near the lower limit of the 
calibration curve (1.25 μM). 
We undertook the fluorescence-based NADPH assay with 
the exogenous substrate 4-PB. We identified 23/31 BM3 variants 
exhibiting higher NADPH consumption in the presence of 4-PB. 
Hydroxylation of 4-PB was confirmed by GC-MS for 8/23 variants 
(Table S2; Figure S6). As for indole oxidation, this demonstrates 
that substrate-specific NADPH consumption overestimates 
product formation. Among the eight variants with detectable 
hydroxylated 4-PB, four gave concentrations ≥ 2.5 μM (2 x lower 
limit of the calibration curve) and are qualified as producers 
(Figure 4; Table S3). Three are variants of position A82 and one 
of position V78; no indigo-positive variant of positions 87 or 264 
hydroxylated 4-PB at significant concentrations, despite variants 
of position 87 being among the best indigo producers (Figure 3).  
These samples have the same mass and retention time as 
the raspberry ketone standard, consistent with p-hydroxylation of 
the phenyl ring. We confirmed the production of raspberry ketone 
as the sole oxidation product by preparative LC and 1H-NMR with 
a scaled-up reaction of the most efficient variant, A82Q (Figure 
S7). Strikingly, A82Q and the seven further variants that 
hydroxylate 4-PB are all indigo producers; we note that variant 
A82Q has not previously been reported in the context of indigo 
synthesis. Our results support the initial hypothesis that indigo is 
a good predictor for raspberry ketone production. We further 
demonstrate that Abs620 is sufficient to identify promiscuous 
variants (Figure 4). 
Although the fluorescence-based NADPH consumption 
assay overestimated the number of variants of interest, it 
enclosed a second predictor of promiscuity. Three distinct 
NADPH consumption patterns were observed: A) no observable 
consumption; B) faster consumption in presence then in absence 
of exogenous substrate; C) very fast consumption both in 
presence and absence of exogenous substrate (Figure S3). The 
latter was observed for 9 variants (Figure 4; Table S2). Variants 
that rapidly consumed NADPH in absence of exogenous 
substrate could have been thought to exhibit high uncoupling. 
However, 7/9 fast NADPH consumers were active for indigo 
formation and 3/9 among those seven were active for raspberry 
ketone and include the most active variant, A82Q (Figure 4; Table 
S3). Performing the assay at a lower concentration of NADPH 
(0.375 mM instead of 1.5 mM) also successfully identified 6 
variants that consume NADPH rapidly in absence of exogenous 
substrate, where 6/6 were indigo producers and 5/6 were 
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raspberry ketone producers (data not shown). Considering that 3 
out of 4 of the raspberry ketone producers were identified, this 
suggests that fast NADPH consumption is a good indicator of 
activity toward promiscuous substrates. 
This work along with previous reports clearly demonstrate 
that indigo production is a predictor of varied promiscuous 
reactions. [10a-c] Here, determination of Abs620 in bacterial lysate 
served as a rapid screening tool that is compatible with large 
libraries. It reduced by 74% the number of samples to analyze by 
MS for indigo and raspberry ketone production with only one false 
positive. If indigo is not a good predictor for a desired reaction, 
performing the CO-difference assay, the fluorescence-based 
NADPH assay and MS quantification may be a robust alternative. 
In our case, this workflow reduced by 45% and 57% the number 
of samples to analyze by MS for indigo and raspberry ketone 
production, respectively. The fast NADPH-consuming variants 
reduced the need for MS analysis by > 80% for both reactions. It 
identified 7 of the 14 indigo producers and 3 of the 4 raspberry 
ketone producers, mainly the most active (Tables S2, S3). The 
workflow provides a universal platform using readily accessible 
methods for screening non-colorigenic reactions and is amenable 
to very high-throughput screening.  
 
Figure 4. Comparison of workflows to enrich the pool of P450 BM3 variants with indigo or raspberry ketone (RK) producers, defined as giving product ≥ 2 × lowest 
concentration in the linear portion of the calibration curve. Black, blue and blue/red circles represent negative variants, indigo-only producers and indigo/raspberry 
ketone producers, respectively. Black, blue, red and yellow arrows represent methods that identify functionally-expressed P450s, indigo production, raspberry 
ketone production and NADPH consumption, respectively. The fraction of variants eliminated at each step is given beside each arrow as a negative percentage. A 
red asterisk identifies the top raspberry ketone producer. 
Table 2. Initial rates of product formation and coupling efficiency for select 
P450 BM3 variants. a 
a NADPH consumption was measured continuously and product formation was 
measured discontinuously, under identical conditions. Reaction mixtures 
contained 5 mM substrate and 250 μM NADPH. 
b RK: raspberry ketone. 
c n.d.: not detected 
We note that the three previously known indigo producers 
did not include the top raspberry ketone producer, variant A82Q, 
demonstrating the importance of considering a broad test-set of 
indigo-positive variants when searching for promiscuous activity.  
Top indigo- or raspberry ketone-producing variants were 
selected for determination of reactivity and coupling efficiency 
(Table 2). Initial reaction rates (first 5%) were determined with 250 
µM NADPH to continuously monitor NADPH consumption. These 
conditions differ from those applied in determination of total indigo 
formed (Figure 3): NADPH is sub-saturating to prevent saturation 
of the signal,[7c] and analysis of initial rates ensures that product 
inhibition is prevented. Results for variants A82F and A82W are 
in the same range as a prior report performed under similar 
conditions.[7a] However, variant A82Q displayed the highest 
specific activity in indigo synthesis (2100 μM/min per mg of A82Q), 
surpassing even well-known indigo-producing variant A82F (1400 
μM/min per mg of A82F; Table 2).[23] It also displayed the highest 
coupling efficiency for this reaction (Table 2).  
Interestingly, we observe a clear correlation between the 
specific activity for indigo and raspberry ketone production 
calculated from initial rates of reaction calculated for the top 
producers (Figure 5). This contrasts with the quantification of total 








 (µM/min product formed 
per mg of enzyme) 
Coupling efficiency   
 (%) 
Indigo RK b NADPH to indigo 
NADPH to 
RK 
A82F 1400 ± 180 35 ± 1 20 0.3 
A82W 580 ± 54 25 ± 8 4.8 0.1 
F87V 410 ± 130 n.d 35 n.d 
A82Q 2100 ± 27 90 ± 2 84 1.8 
WT 8.1 ± 5 n.d 6.3 n.d 
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did not display this correlation (Figure 3, Table S3): the four top 
raspberry ketone producers ranked 1st, 7th, 9th and 11th with 
respect to indigo production, the top raspberry ketone-producing 
variant A82Q ranking 7th for indigo. The characterization of initial 
reaction kinetics thus improves the capacity of indigo formation to 
be predictive of a promiscuous activity. Nonetheless, indigo 
formation is not absolutely predictive of a given promiscuous 
activity: high indigo-producing variants F87V and F87P do not 
display significant reactivity with 4-PB. This reinforces the need to 
broadly screen indigo forming variants for promiscuous reactivity. 
 
Figure 5. Specific activities of indigo (blue) and raspberry ketone (red) 
production for select, top indigo- or raspberry ketone-producing variants as per 
Table 2. Initial rates were determined with discontinuous assays of indigo and 
raspberry ketone production. Error bars represent the standard deviation on the 
mean of triplicate measurements. 
 
Variant A82Q benefits from better productive binding toward 
4-PB (KMapp = 120 µM) than the second-best variant, A82F (KMapp 
= 410 µM). This is counterbalanced by a 2-fold lower turnover rate 
(kcatapp = 14 vs 30 s-1), resulting in similar catalytic efficiencies 
(Table 3). The comparatively high productivity of raspberry ketone 
by variant A82Q (Figure 3) appears to result from it displaying 
both the highest initial rate of NADPH consumption and the 
greatest coupling efficiency for this reaction (Table 2). 
Nonetheless, its initial rate (90 μM/min per mg of A82Q) and 
coupling efficiency (1.8 %) in the presence of 4-PB were 24 and 
45-fold lower, respectively, than those in the presence of indole. 
Although the productivity of raspberry ketone is modest, these 
results clearly identify variant A82Q as a candidate for 
optimization of this promising reaction. It also indicates that 
variant A82Q should be considered when panning variants of 
P450 BM3 for promiscuous oxidation reactions. 
 
 
Table 3.  Kinetic parameters of the oxidation of indole and 4-phenyl-2-butanone 
(4-PB) by P450 BM3 variants A82F and A82Q. a 
Substrate: Indole 4-PB 
P450 BM3 variant: A82Q A82F A82Q A82F 
KMapp (µM) b 140 ± 18 590 ± 83 120 ± 23 410 ± 67 
kcatapp (s-1) 6.7 ± 0.2 17 ± 0.7 14 ± 0.4 30 ± 1 
kcat/KMapp (µM-1.s-1) 0.05 0.03 0.1 0.07 
a NADPH consumption at varying substrate concentrations (0.125 – 5 mM for 
indole and 0.125 – 10 mM for 4-PB) and 250 μM NADPH. Representative 
Michaelis-Menten plots are shown in Figure S8. 
b app: Kinetic parameters are reported as apparent because NADPH was 
subsaturating. This allowed determining initial rates by absorbance at 340 nm. 
 
In conclusion, we report 11 previously unknown variants of 
P450 BM3 that oxidize indole to indigo and we clearly 
demonstrate the utility of including lower-yielding variants in the 
search for promiscuous oxidation activity on new substrates. 
Direct identification of indigo formation by absorbance or 
identification by the more time-consuming LC-MS gave similar 
results; culling inactive variants by CO difference spectroscopy 
prior to LC-MS was advantageous.  By those means, all raspberry 
ketone-producing variants were identified. A straightforward, 
alternative route to discovery of promiscuous activity was also 
discovered: fast NADPH-consuming variants identified many of 
the most active indigo producers and 3 of the 4 raspberry ketone 
producers, and most effectively reduced the need for MS analysis.  
We have thus engineered variants of P450 BM3 that 
produce raspberry ketone with a yield in the range of previously 
reported indigo-producing variants. The breadth of new oxidation 
reactions that can be accessed on the basis of indigo production 
is yet unknown; these methods promise to accelerate discovery 
of new reactivities.  
Experimental Section 
Materials 
The primers for mutagenesis were obtained from Sigma-Aldrich. 
Phusion Hot start II polymerase, purification kit, gel extraction kit and 
miniprep kit were obtained from New England Biolabs. FastDigest 
restriction enzymes and fast alkaline phosphatase were obtained from 
Thermo Fisher Scientific. TAKARA ligase was obtained from ClonTech. 
The cloning vector, pcWORI BM3 WT, was kindly provided by Prof. 
Frances Arnold (Caltech). Indole was obtained from Alfa Aesar. 4-phenyl-
2-butanone, raspberry ketone and sodium hydrosulfite were obtained from 
Sigma-Aldrich. FastBreak lysis buffer was obtained from Promega. 
PCR were performed with a T100 thermal cycler from Bio-Rad. 
Cultures were shaken using a Marshall Scientific Labline 4625 titer shaker. 
Screening was performed with a Beckman Coulter Biomek NXP robot 
coupled to a DTX880 multimode detector plate reader. LC-MS analysis 
was performed on a Thermo Scientific Dionex UltiMate 3000 and masses 
were detected with a Finnigan TSQ Quantum Ultra mass detector. GC-MS 
analysis was performed with an Agilent 7890A and masses were detected 
with an Agilent 5975C with triple-axis detector. Preparative LC was 
performed on a Waters apparatus with a SQ Detector 2. Sequencing was 
operated by the Institute Research of Immunology and Cancerology.  
 
Mutagenesis conditions 
Individual mutagenesis reactions were carried out for each position. 
A mixture of four primers encoding: NDT, VMA, ATG or TGG at the position 
of interest was used to perform saturation site-directed mutagenesis at 
each of 5 position: V78, A82, F87, A264 and T268. Primer sequences are 
listed in the Supporting Information (Table S1). The megaprimer method 
of mutagenesis was applied. [29] PCR intermediates were purified before 
proceeding with further steps. Final PCR products were digested using 
BamHI and SacI according to the manufacturer’s instructions. DpnI was 
used to eliminate parental DNA. The gel-purified inserts were ligated into 
the BamHI, SacI and Fast-AP treated pcWORI BM3 WT vector. Chemically 
competent E.coli BL21 (DE3) cells were transformed with each ligation and 
plated on Luria-Bertani (LB) agar with ampicillin (100 μg/mL). 
 
Culture conditions and lysis 
Unless otherwise stated, precultures were grown in 2 mL deep-well 
96-well plates, in 1 mL LB with ampicillin (100 μg/mL) for 16 h at 37°C, 
shaking at intensity 5. Expression was carried in the same format, in 1 mL 
terrific broth (TB) supplemented with ampicillin (100 μg/mL), δ-
aminolevulinic acid (12.5 μg/mL), thiamine (5 μg/mL), 0.125 μL trace 
metals (0.5 g MgCl2, 50 g FeCl2⋅6H2O, 1 g ZnCl2⋅4H2O, 0.2 g CoCl2⋅6H2O), 
1 g Na2MoO4⋅2H2O, 0.5 g CaCl2⋅2H2O, 1 g CuCl2, 0.2 g H2BO5 in 1L HCl 
solution (90% v/v distilled water: concentrated HCl), and 20 μL of 
preculture. The cultures were propagated as above until O.D. reached 0.7-
1.0, induced with 1 mM isopropyl-β-D-thiogalactoside (IPTG) and further 
propagated for 20 h at 22°C with shaking. Cultures were pelleted at 1650 
g, 4°C for 20 min and pellets were frozen for at least 2 h at -80°C. 
Expression pellets were thawed on ice and resuspended in 400 μL lysis 
buffer (10mM MgSO4, 1mM DTT, 0.5 mg/mL lysozyme (Sigma), DNase, 
1.5 mM benzamidine hydrochloride hydrate (Fisher), 0.25 mM PMSF 
(Sigma) in phosphate buffer 0.1M pH 8). Samples were shaken at room 
temperature for 2 h at intensity 8. Lysates were centrifuged at 1643 g, 4°C 
for 20 minutes and supernatants were used for further steps. 
 
CO difference spectroscopy 
A CO chamber was built by modifying a standard Pyrex desiccator 
to include a custom lid with an adjustable gas inlet and outlet. 
Quantification of the P450 BM3 variants was performed based on a 
previously described protocol. [8a] Lysate (160 μL) of each variant was 
reduced with 40 μL of 0.3 M sodium dithionite in 1 M phosphate buffer pH 
8. They were quantified simultaneously in a 96-well plate. A reference 
measurement was taken at 485 nm. Then, the plate was placed in the CO 
chamber with a positive CO pressure for 15 s before releasing the pressure. 
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This cycle was repeated twice. A last cycle was performed with CO held 
for 5 min. The CO difference spectroscopy measurement was immediately 
taken at 485 nm. 
 
High-throughput absorbance and fluorescence screening assay 
Assays were carried out at room temperature in a 96-well plate 
format using 7.5 μL of bacterial lysate, 5 mM substrate (indole or 4-phenyl-
2-butanone) in DMSO (2% final DMSO), 1.5 mM NADPH in a final volume 
of 140 μL with phosphate buffer 0.1 M pH 8. A reference plate was 
analyzed under the same conditions, where substrate was replaced with 
DMSO. Every 30 min, an absorbance measurement was taken at 620 nm 
to monitor indigo formation and a fluorescence measurement was taken in 
parallel (exc 340 nm; em 465 nm) to monitor NADPH consumption, for up 
to 16 h. 
 
Reaction rates and coupling efficiency 
 Reactions were performed at 25°C in potassium phosphate buffer 
0.1 M pH 8 with 250 μM NADPH to allow continuous monitoring of initial 
rates according to NADPH consumption at 340 nm. Initial rates, 
determined according to the first 5% of NADPH consumed, were analyzed. 
Reactions contained 5 mM substrate in DMSO (2% final DMSO) and 
between 0.04 –  0.1 μM enzyme, as determined in lysate by CO difference. 
Product formation was monitored in a discontinuous fashion using identical 
reaction conditions. Indigo formation was determined following quenching 
by addition of 4 parts CHCl3. The spontaneous oxidation of indoxyl to 
indigo took place overnight. The organic layer was extracted by 
centrifugation at 3000 g for 20 min at 4°C. Indigo concentration was 
determined according to absorbance at 620 nm. Raspberry ketone 
formation was monitored by addition of 2 parts ethyl acetate. Samples 
were vortexed for 10 min and centrifuged at 1650  g, at room temperature 
for 5 min. The organic phase was analyzed by GC-MS.  
 NADPH to indigo coupling efficiency accounted for two indole oxidation 
events per molecule of indigo formed:  
([indigo formed]) / (2 × [NADPH consumed]) × 100. 
 NADPH to RK coupling efficiency:  
[RK formed]) / [NADPH consumed] x100. 
  
Steady-state enzyme kinetics 
 All steady-state kinetics were performed at 25°C in potassium 
phosphate buffer 0.1 M pH 8 with 250 μM NADPH to allow continuous 
monitoring of initial rates according to NADPH consumption at 340 nm. 
Kinetic constants were determined using 0.125 – 5 mM indole and 0.125 
– 10 mM 4-PB in DMSO (2% final DMSO). Enzyme concentrations were 
determined in lysate by CO difference, as above, and were between 0.04 
–  0.1 μM. Initial rates, determined as above, were analyzed.  
 
LC-MS/GC-MS analysis 
The indigo reactions were quenched with 300 μL acetonitrile and 15 
μL of FastBreak lysis buffer. Raspberry ketone reactions were quenched 
with 300 μL ethyl acetate. All reactions were shaken for 20 min and 
centrifuged at 1643 g at room temperature for 20 min to remove insoluble 
matter. Supernatant (100 μL) was transferred to a MS vial for analysis. 
For LC-MS of indigo, a Phenomenex RP-polar 2 mm x 150 mm, 4 
μm column was used at 50°C oven temperature. We injected 5 μL and 
applied a gradient of (A) H2O 0.1% formic acid / (B) ACN 0.1% formic acid 
from 40-95% B over 5 min was applied and held for 3 min, then equilibrated 
at 60% A: 40% B for 2 min. Masses were detected under positive ionization 
and single-ion monitoring of indole (118 m/z), indigo (263 m/z) and full 
scan were taken. 
For GC-MS of raspberry ketone, we used an Agilent J&W 122-7033 
DB-WAX 30 m x 250 μm, 0.25 μm or a Zebron ZB-WAXplus 30 m x 250 
μm, 0.25 μm column. In the DB-WAX, we injected 1 μL with an inlet 
temperature of 270°C, pressure of 11.8 psi and a flow of 1.2 mL/min. A 
temperature gradient from 80°C to 240°C in 8.89 min was applied and held 
at 240°C for 16 min. In the ZB-WAXplus, we injected 1 μL with an inlet 
temperature of 280°C, pressure of 11.8 psi and a flow of 1 mL/min. A 
temperature gradient from 190°C to 240°C in 2.28 min was applied and 
held at 240°C for 10 min. Masses were detected under positive ionization 
and single-ion monitoring of the internal standard t-butyl-phenol(135 m/z), 
4-phenyl-2-butanone (121 m/z) and the fragment of raspberry ketone (107 
m/z). 
 
NMR identification of raspberry ketone 
The 4-phenyl-2-butanone oxydation reaction was scaled-up in a 300 
mL Erlenmeyer using 2.5 mL of lysate from variant A82Q, 1mL of 250 mM 
4-phenyl-2-butanone, 5mL of 15 mM NADPH and 41.5 mL of 0.1 M 
potassium phosphate buffer pH 8 in a total volume of 50 mL. The reaction 
was performed for 16 hours at 25°C with shaking at 250 rpm. The product 
was extracted with 100 mL of ethyl acetate and evaporated at 40°C on a 
rotary evaporator and taken up in 1 mL of ethyl acetate for analysis. 
Isolation of the hydroxylated product(s) was done by preparative LC 
with a Phenomenex RP-polar 19 mm x 150 mm, 4μm column. We injected 
8 x 100 μL of the sample. An initial gradient of (A) H2O 0.1% formic acid / 
(B) MeOH 0.1% formic acid from 85-33% B in 13.5 min was applied and 
held at 10% A: 90% B for 1 min, then equilibrated at 15% A: 85% B for 5 
min. We monitored the mass of the raspberry ketone fragment as a sodium 
adduct (107.1 + 22 m/z). Fractions containing the correct mass and 
retention time were collected, combined and evaporated for NMR analysis. 
1H NMR (700 MHz, CDCl3, 25°C, TMS): δ = 7.06 (m, 2H), δ = 6.76 (m, 2H), 
δ = 2.83 (t, J = 7.5 Hz, 2H), δ = 2.72 (t, J = 7.5, 2H), δ = 2.16 (s, 3H) ppm. 
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synthesis by engineered 
cytochrome P450 BM3. 
  
 
 
 
 
